Jan Sperl, Jan Petrasek, Julius Spicak, Ondrej Viklicky. Show Affiliations »
Abstract
Mesh: See more » AdultAntiviral Agents/adverse effectsAntiviral Agents/therapeutic useDose-Response Relationship, DrugFemaleGraft Rejection/chemically inducedGraft Rejection/diagnosisHepatitis C/drug therapyHumansInterferon alpha-2Interferon-alpha/adverse effectsInterferon-alpha/therapeutic useKidney Failure, Chronic/surgeryKidney TransplantationMaleMiddle AgedPolyethylene Glycols/adverse effectsPolyethylene Glycols/therapeutic useRecombinant Proteins
Substances: See more » Antiviral AgentsInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene Glycolspeginterferon alfa-2a
Year: 2008 PMID: 18644649 DOI: 10.1016/j.jhep.2008.06.002
Source DB: PubMed Journal: J Hepatol ISSN: 0168-8278 Impact factor: 25.083